Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2007
10/18/2007WO2007116975A1 METHOD FOR NON-INVASIVE EXAMINATION OF NON-ALCOHOLIC STEATOHEPATITIS BY QUANTIFICATION OF CYTOCHROME-c, AND TEST KIT
10/18/2007WO2007116925A1 hCL-K1 POLYPEPTIDE HAVING COLLECTIN ACTIVITY
10/18/2007WO2007116779A1 Novel platelet activation marker and method for determination thereof
10/18/2007WO2007116597A1 Tumor marker, diagnostic kit for tumor, method for determination of tumor marker, and diagnostic method for tumor
10/18/2007WO2007116360A2 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
10/18/2007WO2007116199A1 Methods and reagents for diagnosing heart failure
10/18/2007WO2007115829A2 Anti ku70 internalizing antibodies
10/18/2007WO2007115814A2 Antibodies against insulin-like growth factor i receptor and uses thereof
10/18/2007WO2007115813A1 Glycosylated antibodies
10/18/2007WO2007115713A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
10/18/2007WO2007087384A3 Methods for modulating mannose content of recombinant proteins
10/18/2007WO2007077543A3 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods
10/18/2007WO2007077464A3 Chicken virus vaccine and diagnostic
10/18/2007WO2007059715A3 Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses
10/18/2007WO2007038658A3 Antibody-drug conjugates and methods of use
10/18/2007WO2007033167A3 Compositions and methods for detecting and treating cancer
10/18/2007WO2007011265A8 Method for blocking noggin2 target specific activities
10/18/2007WO2002088707A3 Biopolymer marker having a molecular weight of 1998 daltons
10/18/2007WO2002010198A3 Polynucleotides and polypeptides
10/18/2007US20070244305 Process for The Manufacture of Virus Safe Immunoglobulin
10/18/2007US20070244304 Methods of Identifying Neoplasm-Specific Antibodies and Uses Thereof
10/18/2007US20070244303 comprising an Fc region derived from a human IgG heavy chain, wherein the Fc region lacks effector function; for the reduction of a deleterious immune response; idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia
10/18/2007US20070244302 Antibodies And Methods For Generating Genetically Altered Antibodies With High Affinity
10/18/2007US20070244061 Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt
10/18/2007US20070244053 Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
10/18/2007US20070244037 Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation
10/18/2007US20070244035 Novel co-modulators of nuclear receptors and methods of detecting and treating steroid hormone-dependent diseases using same
10/18/2007US20070244032 Cancer Cell Targeting Gene Delivery Method
10/18/2007US20070243594 Oxidoreductase from Pichia Capsulata
10/18/2007US20070243589 Antibodies against human IL-22 and uses therefor
10/18/2007US20070243586 Novel organic anion transport proteins
10/18/2007US20070243564 Identification of Antibody-Producing Cells
10/18/2007US20070243549 Enrichment of circulating fetal dna
10/18/2007US20070243541 Compositions and methods for generating antigen-binding units
10/18/2007US20070243208 Novel chimeric protein for prevention and treatment of hiv infection
10/18/2007US20070243206 Using hybrid fibrin peptides to prevent hemophilus infection
10/18/2007US20070243202 Tumor necrosis factor receptor-associated factors
10/18/2007US20070243201 Method for Selecting Epitopes for Immunotherapy
10/18/2007US20070243195 Vaccine against streptococci
10/18/2007US20070243194 Anti-IGF-1R antibodies and uses thereof
10/18/2007US20070243193 Compositions and methods for the diagnosis and treatment of tumor
10/18/2007US20070243191 Anti-hyperproliferative therapies targeting hdgf
10/18/2007US20070243189 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
10/18/2007US20070243188 Fc Variants Having Decreased Affinity for FcyRlla
10/18/2007US20070243187 Methods and Materials for Treating Autoimmune Diseases and Conditions
10/18/2007US20070243176 Human genes and gene expression products
10/18/2007US20070243162 Labeled monoclonal antibody binds Kaposi's sarcoma-associated herpesvirus (KSHV); use in diagnosis and prognosis
10/18/2007CA2849203A1 Glycosylated antibodies
10/18/2007CA2651911A1 Anti ku70 internalizing antibodies
10/18/2007CA2648846A1 Antibody compositions and methods for treatment of neoplastic disease
10/18/2007CA2648718A1 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
10/18/2007CA2648582A1 Conjugates of an anti-tnf-alpha antibody
10/18/2007CA2648330A1 Anti-ccr2 antibody depletes monocytes to treat multiple sclerosis and rheumatoid arthritis
10/18/2007CA2648284A1 Antibodies that bind human protein tyrosine phosphatase beta (hptpbeta) and uses thereof
10/18/2007CA2648188A1 Methods for treating conditions associated with masp-2 dependent complement activation
10/18/2007CA2647524A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
10/18/2007CA2647288A1 Glycosylated antibodies
10/18/2007CA2647181A1 Antibodies against insulin-like growth factor i receptor and uses thereof
10/18/2007CA2647029A1 Antibody purification
10/18/2007CA2646807A1 Novel platelet activation marker and method for determination thereof
10/18/2007CA2638865A1 Methods and compositions for targeting relt
10/18/2007CA2637166A1 Il-17 antagonistic antibodies for treating cancer
10/18/2007CA2616859A1 Compositions and methods for production of immunoglobulins
10/17/2007EP1845376A1 Quantitative measurement method for recombinant protein
10/17/2007EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/17/2007EP1844815A1 Combination therapy comprising anti-CD20 and anti-CD40 antibodies for the treatment of B cell-related cancers
10/17/2007EP1844336A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
10/17/2007EP1844158A2 Biomarker for inflammatory bowel disease
10/17/2007EP1844077A2 Dr5 antibodies and uses thereof
10/17/2007EP1844075A2 Suppressor of disease-associated autoreactive b iymphocytes
10/17/2007EP1844074A2 Human antibodies and proteins
10/17/2007EP1844073A1 Method for generating variable domain sequences of heavy chain antibodies
10/17/2007EP1578372A4 Ca125 gene and its use for diagnostic and therapeutic interventions
10/17/2007EP1427758B1 Compositions and methods of treating diabetes
10/17/2007EP1276770B1 Proteins with a high immunoreactivity and a method for the production thereof
10/17/2007EP1144006B1 CCR5 Antibody PA14
10/17/2007EP1123387B1 Mn gene and protein
10/17/2007EP1092018B1 Kv6.2, A VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT
10/17/2007EP1076710B1 Factors affecting tumor necrosis factor receptor releasing enzyme activity
10/17/2007EP0993613B8 Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumours originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
10/17/2007CN101056979A Anti-histone H1 monoclonal antibody and hybridoma capable of producing the same
10/17/2007CN101056655A Methods of treating CD30 positive lymphomas
10/17/2007CN101054596A Recombination adenovirus for curing overexpression proto-oncogene neu/erbB2 malignancy
10/17/2007CN101054417A Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor
10/17/2007CN101054416A HAb18GC2 monoclonal antibody and its light and heavy chain variable area genes, coding polypeptide and use
10/17/2007CN101054415A Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein
10/17/2007CN101054413A Tumor correlated albumen, coding gene and application thereof
10/17/2007CN101053561A Methods and compositions useful for inhibition of alpha v beta 5 mediated angiogenesis
10/17/2007CN100343282C Hybrid interferon compositions and methods of use
10/17/2007CN100343281C Axin antibody C8 preparation method
10/17/2007CN100343280C CUDR as biomarker for cancer progression and therapeutic response
10/16/2007US7282625 Using plants as bioreactors for biosynthesis of functional antibodies
10/16/2007US7282590 Drug conjugates
10/16/2007US7282577 Nucleotide sequences coding hemolytic protein for use tool in treatment of jelly fish stings
10/16/2007US7282576 Coactivators in the diagnosis and treatment of breast cancer
10/16/2007US7282570 Nucleotide sequences for use in the treatment and diagnosis of immunological and inflammatory disorders
10/16/2007US7282569 PRO1508 antibodies
10/16/2007US7282568 Human monoclonal antibodies against interleukin 8 (IL-8)
10/16/2007US7282567 Monoclonal antibody hPAM4
10/16/2007US7282566 PRO1779 polypeptide
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1494